Digest Réseau Comment ça marche
Réseau
/
Sociétés
AC
Non vérifié

AC Immune SA

Ce que nous écrivons

Annonces ÉconomiquesBiotechnologieManagement/Organisation d'EntrepriseMédecine Santé Bien-êtrePublicité/Marketing/Médias/Communication

17 communiqués de presse

Voir tous les communiqués de presse
11/12/2025
Biotechnologie
AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s Disease
Source
AC Immune SA
Émetteur
GLOBENEWSWIRE
1.00
0
11/11/2025
Biotechnologie
AC Immune to Present at the Jefferies 2025 London Healthcare Conference
Source
AC Immune SA
Émetteur
GLOBENEWSWIRE
1.00
0
04/11/2025
Biotechnologie
Management/Organisation d'Entreprise
AC Immune Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
Source
AC Immune SA
Émetteur
GLOBENEWSWIRE
1.00
0
28/10/2025
Biotechnologie
Annonces Économiques
AC Immune Appoints Renowned Neurologist Catherine Mummery as Chair of Clinical Advisory Board
Source
AC Immune SA
Émetteur
GLOBENEWSWIRE
1.00
0
24/10/2025
Biotechnologie
Publicité/Marketing/Médias/Communication
Médecine Santé Bien-être
First Characterization of a TDP-43 PET Tracer Published in Nature Communications Showing Potential of AC Immune’s ACI-19626 in Precision Medicine
Source
AC Immune SA
Émetteur
GLOBENEWSWIRE
1.00
0
25/09/2025
Biotechnologie
Peer-reviewed results from Phase 1b/2a Trial of Anti-pTau Active Immunotherapy from AC Immune Published in eBioMedicine
Source
AC Immune SA
Émetteur
GLOBENEWSWIRE
1.00
0
04/09/2025
Biotechnologie
Annonces Économiques
Finance
AC Immune Sharpens Pipeline Focus with Operational Efficiencies Extending Cash Runway
Source
AC Immune SA
Émetteur
GLOBENEWSWIRE
1.00
0
05/08/2025
Biotechnologie
Management/Organisation d'Entreprise
Annonces Économiques
Publicité/Marketing/Médias/Communication
AC Immune Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
Source
AC Immune SA
Émetteur
GLOBENEWSWIRE
1.00
0
30/04/2025
Biotechnologie
Management/Organisation d'Entreprise
Médecine Santé Bien-être
Publicité/Marketing/Médias/Communication
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update
Source
AC Immune SA
Émetteur
GLOBENEWSWIRE
1.00
0
02/04/2025
Biotechnologie
AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
Source
AC Immune SA
Émetteur
GLOBENEWSWIRE
1.00
0

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0